Company news
Shield Therapeutics PLC news in 2020
Shield Therapeutics PLC's news releases, calls and decks from 2020, newest first.
PDMR Exercise of Share Options
December 18, 2020
Update re US partnering discussions
December 10, 2020
Withdrawal of all oppositions by TEVA
October 19, 2020
Shield Therapeutics (STX): Optimism over US deal
September 18, 2020
AEGIS-H2H study reanalysis
August 6, 2020
Total Voting Rights update
July 31, 2020
PT20 paper publication
July 16, 2020
Appointment of Non-Executive Director
June 26, 2020
Results of 2020 Annual General Meeting
June 18, 2020
Feraccru®/Accrufer® publications
June 3, 2020
Investor presentations
May 28, 2020
Appointment of Chairman
May 26, 2020
2019 Annual Report and 2020 AGM Notice
May 22, 2020
Shield Therapeutics (STX): Reassuring trading u...
May 11, 2020
Further re. Directorate Change
April 27, 2020
AEGIS-H2H study update
March 17, 2020
Shield Therapeutics (STX): Good demand for Fera...
January 28, 2020
Shield Therapeutics (STX): Taking on China
January 14, 2020
China licence agreement for Feraccru/Accrufer
January 8, 2020
Calls in 2020
Decks in 2020
- Investor Presentation (December 2020)
Investor deck · 29 slides · Dec 16, 2020
- H1 2020 Earnings Presentation
Earnings · 21 slides · September 2020